These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3792230)

  • 1. The polyol pathway. A historical review.
    Clements RS
    Drugs; 1986; 32 Suppl 2():3-5. PubMed ID: 3792230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of polyols in the development of diabetic complications. Value of aldose-reductase inhibitors].
    Brogard JM; Caro-Sampara F; Blicklé JF
    Rev Med Interne; 1992; 13(1):69-79. PubMed ID: 1410879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pyruvate on lens myo-inositol transport and polyol formation in diabetic cataract.
    Beyer-Mears A; Diecke FP; Mistry K; Ellison C; Cruz E
    Pharmacology; 1997 Aug; 55(2):78-86. PubMed ID: 9323307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the polyol pathway in the occurrence of degenerative complications of diabetes].
    Bosquet F; Grimaldi A
    Presse Med; 1986 May; 15(19):879-83. PubMed ID: 3012508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aldose reductase in the development of diabetes-associated complications.
    Kador PF; Kinoshita JH
    Am J Med; 1985 Nov; 79(5A):8-12. PubMed ID: 3934965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
    Hotta N
    Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and vascular factors in the pathogenesis of diabetic neuropathy.
    Ward JD
    Clin Invest Med; 1995 Aug; 18(4):267-74. PubMed ID: 8549012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorbitol, myo-inositol and sodium-potassium ATPase in diabetic peripheral nerve.
    Greene DA
    Drugs; 1986; 32 Suppl 2():6-14. PubMed ID: 3024950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes on the free polyol pattern in cataractous lenses.
    Yoshioka S; Kameyama K; Sanaka M; Sekine I; Kagimoto S; Fujitsuka S; Saitoh S
    Clin Chem; 1991 May; 37(5):686-9. PubMed ID: 2032321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of electroretinogram abnormalities and the possible role of polyol pathway activity in diabetic hyperglycemia and galactosemia.
    Segawa M; Hirata Y; Fujimori S; Okada K
    Metabolism; 1988 May; 37(5):454-60. PubMed ID: 3285132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and morphological changes during development of sugar cataract in Otsuka Long-Evans Tokushima fatty (OLETF) rat.
    Kubo E; Maekawa K; Tanimoto T; Fujisawa S; Akagi Y
    Exp Eye Res; 2001 Sep; 73(3):375-81. PubMed ID: 11520112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
    Cameron NE; Cotter MA
    Diabetes; 1997 Sep; 46 Suppl 2():S31-7. PubMed ID: 9285496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbitol and other polyols in lens, adipose tissue and urine in diabetes mellitus.
    Heaf DJ; Galton DJ
    Clin Chim Acta; 1975 Aug; 63(1):41-7. PubMed ID: 1181073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic neuropathies. Metabolism of sorbitol in sciatic nerve tissue in streptozotocin diabetes].
    Kryvko IuIa; Kozyts'kyĭ ZIa; Serhiienko OO; Kuchmerovs'ka TM; Velykyĭ MM
    Ukr Biokhim Zh (1999); 2001; 73(5):69-74. PubMed ID: 12035507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity.
    Yoshii H; Uchino H; Ohmura C; Watanabe K; Tanaka Y; Kawamori R
    Diabetes Res Clin Pract; 2001 Feb; 51(2):115-23. PubMed ID: 11165691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.